Supporting the development and regulatory activities for the AstraZeneca-Oxford COVID-19 vaccine
The approval in December for the emergency use of the AstraZeneca-Oxford COVID-19 vaccine by the MHRA provided another key milestone in the response to the pandemic. With the COVID-19 vaccine now in wide use across the UK, Professor Alan Boyd reflects on the team’s involvement in this vital and ground-breaking project. Professor Alan Boyd said, […]